Article Details

Candel Therapeutics Completes Enrollment in Phase 3 Clinical Trial of CAN-2409 in ...

Retrieved on: 2021-09-07 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Candel Therapeutics Completes Enrollment in Phase 3 Clinical Trial of CAN-2409 in .... View article details on hiswai:

Excerpt

... immune stimulatory environment and is designed to activate the body's immune system to recognize and destroy cancer cells,” said Paul Peter Tak, M.D., ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up